With reference to the notice of Board Meeting dated August 04 2023 we hereby inform that the Board of Directors at its Meeting held on August 12 2023 (commenced at 10.05 a.m. and concluded at 10.45 a.m.) has inter alia approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2023.In view of the aforesaid we are enclosing the following:- Annexure I - Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2023 along with the Limited Review report issued by MSKA & Associates Statutory Auditors of the Company as an Annexure.The aforesaid financial results and other documents are also being uploaded on the website of the Company i.e. www.advancedenzymes.com
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
